The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[{2-[2-(acetylamino)-4-hydroxypteridin-6-yl]ethyl}(methyl)amino]benzoic acid ID: ALA209381
PubChem CID: 135441514
Max Phase: Preclinical
Molecular Formula: C18H18N6O4
Molecular Weight: 382.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)Nc1nc(O)c2nc(CCN(C)c3ccc(C(=O)O)cc3)cnc2n1
Standard InChI: InChI=1S/C18H18N6O4/c1-10(25)20-18-22-15-14(16(26)23-18)21-12(9-19-15)7-8-24(2)13-5-3-11(4-6-13)17(27)28/h3-6,9H,7-8H2,1-2H3,(H,27,28)(H2,19,20,22,23,25,26)
Standard InChI Key: CLUYOQSENFIUNI-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
12.7024 -9.5249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9912 -8.2883 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7024 -10.3493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4178 -10.7615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1331 -10.3493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1331 -9.5249 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4178 -9.1127 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8443 -10.7615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5596 -10.3493 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.8443 -11.5859 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.9912 -9.1127 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4178 -12.0023 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1332 -11.5901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1332 -10.7657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4178 -10.3535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7025 -10.7657 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.7025 -11.5901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8485 -12.0023 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.8485 -10.3535 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8485 -9.5291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.1332 -9.1169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4178 -9.5291 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.9913 -12.0023 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.5597 -9.1169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2760 -11.5901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2760 -10.7657 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.2744 -9.5279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5617 -12.0029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 7 2 0
7 1 1 0
5 8 1 0
8 9 1 0
8 10 2 0
11 1 1 0
11 2 1 0
1 3 2 0
3 4 1 0
4 5 2 0
12 13 2 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 12 1 0
13 18 1 0
14 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 15 2 0
17 23 1 0
20 24 1 0
23 25 1 0
25 26 2 0
5 6 1 0
24 27 1 0
27 11 1 0
25 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 382.38Molecular Weight (Monoisotopic): 382.1390AlogP: 1.46#Rotatable Bonds: 6Polar Surface Area: 141.43Molecular Species: ACIDHBA: 8HBD: 3#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.75CX Basic pKa: 3.24CX LogP: 1.55CX LogD: -0.91Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.58Np Likeness Score: -1.12
References 1. Dayam R, Aiello F, Deng J, Wu Y, Garofalo A, Chen X, Neamati N.. (2006) Discovery of small molecule integrin alphavbeta3 antagonists as novel anticancer agents., 49 (15): [PMID:16854058 ] [10.1021/jm051296s ]